{"id":"https://openalex.org/W3000519059","doi":"https://doi.org/10.1016/j.ctarc.2020.100165","title":"The emerging landscape of germline variants in urothelial carcinoma: Implications for genetic testing","display_name":"The emerging landscape of germline variants in urothelial carcinoma: Implications for genetic testing","publication_year":2020,"publication_date":"2020-01-01","ids":{"openalex":"https://openalex.org/W3000519059","doi":"https://doi.org/10.1016/j.ctarc.2020.100165","mag":"3000519059","pmid":"https://pubmed.ncbi.nlm.nih.gov/31982787"},"language":"en","primary_location":{"id":"doi:10.1016/j.ctarc.2020.100165","doi":"https://doi.org/10.1016/j.ctarc.2020.100165","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ctarc.2020.100165","pdf_url":"https://www.sciencedirect.com/science/article/pii/S2468294220300022/pdf","source":{"id":"https://openalex.org/S4210186504","display_name":"Cancer Treatment and Research Communications","issn_l":"2468-2942","issn":["2468-2942"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Treatment and Research Communications","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.sciencedirect.com/science/article/pii/S2468294220300022/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061020970","display_name":"Panagiotis J. Vlachostergios","orcid":"https://orcid.org/0000-0002-1704-1517","observed_orcids":["https://orcid.org/0000-0002-1704-1517"]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Panagiotis J. Vlachostergios","raw_affiliation_strings":["Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, United States"],"raw_orcid":"https://orcid.org/0000-0002-1704-1517","affiliations":[{"raw_affiliation_string":"Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, United States","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040904315","display_name":"Bishoy M. Faltas","orcid":"https://orcid.org/0000-0002-6432-1693","observed_orcids":["https://orcid.org/0000-0002-6432-1693"]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bishoy M. Faltas","raw_affiliation_strings":["Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, United States; Department of Cell and Developmental Biology, Weill Cornell Medicine, New York, NY, United States; Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, United States","Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, United States","Department of Cell and Developmental Biology, Weill Cornell Medicine, New York, NY, United States","Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, United States"],"raw_orcid":"https://orcid.org/0000-0002-6432-1693","affiliations":[{"raw_affiliation_string":"Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, United States; Department of Cell and Developmental Biology, Weill Cornell Medicine, New York, NY, United States; Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, United States","institution_ids":["https://openalex.org/I4387153466"]},{"raw_affiliation_string":"Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, United States","institution_ids":["https://openalex.org/I4387153466"]},{"raw_affiliation_string":"Department of Cell and Developmental Biology, Weill Cornell Medicine, New York, NY, United States","institution_ids":["https://openalex.org/I4387153466"]},{"raw_affiliation_string":"Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, United States","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073268337","display_name":"Maria Isabel Carlo","orcid":"https://orcid.org/0000-0002-4786-7408","observed_orcids":["https://orcid.org/0000-0002-4786-7408"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maria I. Carlo","raw_affiliation_strings":["Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073541359","display_name":"Amin H. Nassar","orcid":"https://orcid.org/0000-0002-8084-9105","observed_orcids":["https://orcid.org/0000-0002-8084-9105"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amin H. Nassar","raw_affiliation_strings":["Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States"],"raw_orcid":"https://orcid.org/0000-0002-8084-9105","affiliations":[{"raw_affiliation_string":"Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001568490","display_name":"Sarah Abou Alaiwi","orcid":"https://orcid.org/0000-0002-7073-3432","observed_orcids":["https://orcid.org/0000-0002-7073-3432"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sarah Abou Alaiwi","raw_affiliation_strings":["Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, DANA 1230, Boston, MA 02215, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, DANA 1230, Boston, MA 02215, United States","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052069729","display_name":"Guru Sonpavde","orcid":"https://orcid.org/0000-0002-1010-9611","observed_orcids":["https://orcid.org/0000-0002-1010-9611"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Guru Sonpavde","raw_affiliation_strings":["Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, DANA 1230, Boston, MA 02215, United States. Electronic address: gurup_sonpavde@dfci.harvard.edu","Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, DANA 1230, Boston, MA 02215, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, DANA 1230, Boston, MA 02215, United States. Electronic address: gurup_sonpavde@dfci.harvard.edu","institution_ids":["https://openalex.org/I4210117453","https://openalex.org/I4210134579"]},{"raw_affiliation_string":"Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, DANA 1230, Boston, MA 02215, United States","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5052069729"],"corresponding_institution_ids":["https://openalex.org/I4210117453","https://openalex.org/I4210134579"],"apc_list":{"value":650,"currency":"USD","value_usd":650},"apc_paid":{"value":650,"currency":"USD","value_usd":650},"fwci":1.6127,"has_fulltext":true,"cited_by_count":22,"citation_normalized_percentile":{"value":0.81909539,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"23","issue":null,"first_page":"100165","last_page":"100165"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.4587000012397766,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.4587000012397766,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.31349998712539673,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11369","display_name":"Genetic factors in colorectal cancer","score":0.15199999511241913,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/urothelial-carcinoma","display_name":"urothelial carcinoma","score":0.9980000257492065},{"id":"https://openalex.org/keywords/germline-mutations","display_name":"germline mutations","score":0.9629999995231628},{"id":"https://openalex.org/keywords/genetic-testing","display_name":"genetic testing","score":0.7210000157356262},{"id":"https://openalex.org/keywords/lynch-syndrome","display_name":"Lynch syndrome","score":0.9700000286102295},{"id":"https://openalex.org/keywords/dna-mismatch-repair","display_name":"DNA mismatch repair","score":0.703000009059906},{"id":"https://openalex.org/keywords/dna-repair-genes","display_name":"DNA repair genes","score":0.8370000123977661},{"id":"https://openalex.org/keywords/hereditary-cancer-susceptibility","display_name":"hereditary cancer predisposition","score":0.6959999799728394},{"id":"https://openalex.org/keywords/upper-tract-urothelial-carcinoma","display_name":"upper tract urothelial carcinoma","score":0.828000009059906},{"id":"https://openalex.org/keywords/bladder-cancer","display_name":"bladder cancer","score":0.7229999899864197},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.8830000162124634},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.996999979019165},{"id":"https://openalex.org/keywords/cancer-surveillance","display_name":"cancer surveillance","score":0.6779999732971191}],"concepts":[{"id":"https://openalex.org/C2780673598","wikidata":"https://www.wikidata.org/wiki/Q285223","display_name":"Genetic testing","level":2,"score":0.6905863881111145},{"id":"https://openalex.org/C109825262","wikidata":"https://www.wikidata.org/wiki/Q1139164","display_name":"Germline","level":3,"score":0.6856284737586975},{"id":"https://openalex.org/C60748783","wikidata":"https://www.wikidata.org/wiki/Q2984243","display_name":"DNA mismatch repair","level":4,"score":0.5015368461608887},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5003421306610107},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4902423024177551},{"id":"https://openalex.org/C134935766","wikidata":"https://www.wikidata.org/wiki/Q210538","display_name":"DNA repair","level":3,"score":0.45112743973731995},{"id":"https://openalex.org/C32220436","wikidata":"https://www.wikidata.org/wiki/Q2072214","display_name":"Personalized medicine","level":2,"score":0.43634501099586487},{"id":"https://openalex.org/C13514818","wikidata":"https://www.wikidata.org/wiki/Q5552256","display_name":"Germline mutation","level":4,"score":0.42236271500587463},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4117822051048279},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.3861524760723114},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.38567784428596497},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.36688166856765747},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.32394838333129883},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.31113940477371216},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.24085986614227295},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.1706255078315735}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1016/j.ctarc.2020.100165","doi":"https://doi.org/10.1016/j.ctarc.2020.100165","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ctarc.2020.100165","pdf_url":"https://www.sciencedirect.com/science/article/pii/S2468294220300022/pdf","source":{"id":"https://openalex.org/S4210186504","display_name":"Cancer Treatment and Research Communications","issn_l":"2468-2942","issn":["2468-2942"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Treatment and Research Communications","raw_type":"journal-article"},{"id":"pmid:31982787","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31982787","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer treatment and research communications","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:d1c4454e60f7474586e2b349e36fe4f7","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/d1c4454e60f7474586e2b349e36fe4f7","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Cancer Treatment and Research Communications, Vol 23, Iss , Pp 100165- (2020)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.ctarc.2020.100165","doi":"https://doi.org/10.1016/j.ctarc.2020.100165","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ctarc.2020.100165","pdf_url":"https://www.sciencedirect.com/science/article/pii/S2468294220300022/pdf","source":{"id":"https://openalex.org/S4210186504","display_name":"Cancer Treatment and Research Communications","issn_l":"2468-2942","issn":["2468-2942"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Treatment and Research Communications","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320306257","display_name":"Boehringer Ingelheim","ror":"https://ror.org/05kffp613"},{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320309086","display_name":"Celgene","ror":"https://ror.org/0527yg379"},{"id":"https://openalex.org/F4320312140","display_name":"Exelixis","ror":"https://ror.org/01e3jga91"},{"id":"https://openalex.org/F4320314458","display_name":"National Comprehensive Cancer Network","ror":"https://ror.org/0465x5x63"},{"id":"https://openalex.org/F4320315730","display_name":"Bayer Fund","ror":"https://ror.org/02c8q2v13"},{"id":"https://openalex.org/F4320322148","display_name":"Eisai","ror":"https://ror.org/04vvh7p27"},{"id":"https://openalex.org/F4320323024","display_name":"Astellas Pharma","ror":"https://ror.org/01cjash87"},{"id":"https://openalex.org/F4320330131","display_name":"Bavarian Nordic","ror":"https://ror.org/01gp83d60"},{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3000519059.pdf","grobid_xml":"https://content.openalex.org/works/W3000519059.grobid-xml"},"referenced_works_count":48,"referenced_works":["https://openalex.org/W2001425353","https://openalex.org/W2003665515","https://openalex.org/W2003752323","https://openalex.org/W2003888060","https://openalex.org/W2007353950","https://openalex.org/W2012014972","https://openalex.org/W2018740760","https://openalex.org/W2128024417","https://openalex.org/W2135674762","https://openalex.org/W2140563000","https://openalex.org/W2150791133","https://openalex.org/W2160092994","https://openalex.org/W2162130153","https://openalex.org/W2166139712","https://openalex.org/W2204191358","https://openalex.org/W2225530246","https://openalex.org/W2513490914","https://openalex.org/W2515781164","https://openalex.org/W2523216993","https://openalex.org/W2529123841","https://openalex.org/W2566723262","https://openalex.org/W2604133535","https://openalex.org/W2604999963","https://openalex.org/W2622499649","https://openalex.org/W2656988682","https://openalex.org/W2742139725","https://openalex.org/W2759930271","https://openalex.org/W2762272043","https://openalex.org/W2774605139","https://openalex.org/W2784355197","https://openalex.org/W2800275843","https://openalex.org/W2803332630","https://openalex.org/W2887713819","https://openalex.org/W2890671126","https://openalex.org/W2891500627","https://openalex.org/W2891749509","https://openalex.org/W2898637442","https://openalex.org/W2904125198","https://openalex.org/W2911188335","https://openalex.org/W2915944698","https://openalex.org/W2920845479","https://openalex.org/W2937481540","https://openalex.org/W2943184264","https://openalex.org/W2947560827","https://openalex.org/W2949886398","https://openalex.org/W2954656275","https://openalex.org/W2992811978","https://openalex.org/W2995672471"],"related_works":["https://openalex.org/W4407699631","https://openalex.org/W7171542619","https://openalex.org/W2995672471","https://openalex.org/W2947560827","https://openalex.org/W2992811978","https://openalex.org/W4407701172","https://openalex.org/W4399394424","https://openalex.org/W4226161311","https://openalex.org/W3189693195","https://openalex.org/W2920845479"],"abstract_inverted_index":{"Urothelial":[0],"carcinoma":[1],"(UC)":[2],"of":[3,14,23,42,49,54,75,105,113,120,129,147],"the":[4,15,21,52,55,58,101,111,127,145,167,179],"bladder":[5],"and":[6,46,65,83,92,116,132,142,154,175,192],"upper":[7,62],"tract":[8,63],"(ureter,":[9],"renal":[10],"pelvis)":[11],"is":[12],"one":[13],"most":[16],"frequently":[17],"occurring":[18],"malignancies.":[19],"While":[20],"majority":[22],"UC":[24,50,64,173],"are":[25,96],"chemically":[26],"induced":[27],"by":[28],"smoking,":[29],"accumulating":[30],"evidence":[31],"from":[32],"genetic":[33,103,114,158],"studies":[34],"have":[35],"demonstrated":[36],"a":[37,72],"small,":[38],"but":[39],"consistent":[40],"impact":[41],"heritable":[43,102],"gene":[44,86],"variants":[45,87],"family":[47,133],"history":[48],"on":[51,81,100],"development":[53],"disease.":[56],"Beyond":[57],"established":[59],"association":[60],"between":[61],"germline":[66,157],"mismatch":[67],"DNA":[68,89],"repair":[69,91],"defects":[70],"as":[71,152],"defining":[73],"feature":[74],"Lynch":[76],"syndrome,":[77],"newer":[78],"investigations":[79],"focusing":[80],"moderate-":[82],"high-risk":[84],"cancer-related":[85],"in":[88,110,117,126,178],"damage":[90],"other":[93,148],"signaling":[94],"pathways":[95],"expanding":[97],"our":[98,139],"knowledge":[99],"basis":[104],"UC,":[106],"opening":[107],"new":[108],"avenues":[109],"breadth":[112],"testing":[115,135,140],"clinical":[118],"counseling":[119],"these":[121],"patients.":[122],"Overcoming":[123],"existing":[124],"challenges":[125],"interpretation":[128],"uncertain":[130],"findings":[131],"cascade":[134],"may":[136],"help":[137],"expand":[138],"approach":[141],"guidelines.":[143],"Following":[144],"paradigm":[146],"tumor":[149],"types,":[150],"such":[151],"breast":[153],"ovarian":[155],"cancers,":[156],"testing,":[159,165],"particularly":[160],"when":[161],"combined":[162],"with":[163,185],"somatic":[164],"has":[166],"potential":[168],"to":[169],"directly":[170],"benefit":[171],"affected":[172],"patients":[174],"their":[176],"families":[177],"future":[180],"through":[181],"therapeutic":[182],"targeting":[183],"(i.e.":[184],"poly(ADP-ribose))":[186],"polymerase":[187],"inhibitors,":[188],"immune":[189],"checkpoint":[190],"inhibitors)":[191],"genetically":[193],"informed":[194],"screening/surveillance,":[195],"respectively.":[196]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":2}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2020-01-23T00:00:00"}